
About
Panosome is a biotechnology company and spin-off from the German Cancer Research Center (DKFZ) focused on antibody discovery and development. It works from Heidelberg, Germany, and develops highly specific antibodies against challenging targets for research collaborations and therapeutic advancement.
Services
Antibody discovery platform
Uses the proprietary VAST (VSG-Immunogen Array by Sortase Tagging) technology to generate antibodies against challenging targets.
Antibody development
Develops highly specific antibodies and advances them toward therapeutic applications.
Antibody identification & profiling
Identifies and profiles antibody candidates as part of the discovery workflow.
Antibody characterization & validation
Characterizes and validates antibody candidates.
Research collaborations
Partners on scientific research projects and collaborations.
Scientific partnerships
Works with partners on antibody innovation and development efforts.
Antibody discovery using VAST platform
Uses the VAST (VSG-Immunogen Array by Sortase Tagging) technology to generate high-affinity antibodies against challenging targets.
Platform and assay development
Develops platform and assay capabilities to support antibody discovery programs.
Capabilities
- Assays and studies
- Antibodies
- Antibody profiling
- Antibody characterization
- Antibody validation
- Therapeutic areas
- Oncology
- Inflammation
- Inflammatory diseases
- Biodefense
Modalities and species
- Modalities
- Antibody
- Species and models
- African trypanosomes
Industries served
- Biotechnology
- Life sciences
- Scientific research
Details
- Address
- Carl-Friedrich-Gauß-Ring 5, 69124 Heidelberg
- Serves
- Worldwide